Top Markets
Coin of the day
W World Corp. W World Corp.

W World Corp.

WWHC
株式のランク #22981
W World Corp. is a biopharmaceutical firm dedicated to identifying and... W World Corp. is a biopharmaceutical firm dedicated to identifying and advancing innovative treatments for various metabolic and neurological conditions. Its research and development efforts specifically target ailments related to the brain-gut axis, pain and inflammation, autoimmune diseases, and gout. The company's pipeline features two primary experimental drugs: Levotofisopam, currently in clinical trials as a non-sedative therapy for Gout, and Dextofisopam, a non-serotonergic compound that has successfully concluded Phase IIa and Phase IIb clinical trials for irritable bowel syndrome (IBS). Established in 1990, W World Corp. maintains its corporate headquarters in North Las Vegas, Nevada.
株価
$0.8
最終同期: 2024-01-02
時価総額
$80.24M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 W World Corp. (WWHC)

カテゴリー

W World Corp.(WWHC)の配当利回りの履歴
W World Corp.(銘柄コード: WWHC)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
W World Corp.(WWHC)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)